Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
If you already have an Eversense® account, you do not have to create a new one to use Eversense® NOW.
- Click the link in the email invitation and sign into your existing Eversense® When you refresh the Home Page in your Eversense® NOW App, you will see the name of the CGM user whose invitation you accepted.
If you DO NOT already have an Eversense® account
- When you open the Eversense® NOW App for the first time, accept the End User License Agreement.
Choose the unit of measure. The unit of measure you choose will apply to all of the Eversense® CGM users whose data you can view. You cannot change the unit of measure once the app is installed unless you delete and reinstall the app.
The Eversense® E3 Smart Transmitter will vibrate and the app will provide a “Transmitter Disconnected” notification every 30 minutes, and/or a status bar message, until the app is launched or the smart transmitter is reconnected. Once the connection is re-established, the data collected will sync with the mobile app and the graph will fill in.
To ensure best performance, routine calibration is required using fingerstick readings from a blood glucose meter. DO NOT use alternative test sites such as your forearm when entering BG values for calibration. Any commercially available meter may be used for calibration. Once your sensor has been inserted and linked to your smart transmitter, the system begins a 24-hour Warm-Up Phase. No calibration is required during this phase.
There are three calibration phases:
Initialization Phase – After the 24-hour Warm-Up Phase, you must complete 4 fingerstick calibrations, spaced 2 to 12 hours apart.
2 Daily Calibrations Phase – After the Initialization Phase, you must complete a fingerstick calibration every 12 hours for at least 21 days.
1 Daily Calibration Phase – The system will detect if 1 or 2 daily calibrations are needed and will alert you. In the 1 Daily Calibration Phase, you must complete a fingerstick calibration every 24 hours.
The Eversense® E3 Sensor is approximately 3.5 mm x 18.3 mm.
This Eversense® Smart Transmitter box contains the following:
- Eversense Smart Transmitter
- Charging Cradle
- USB cable
- Wall plug/AC power adapter
- User Guide
- Quick Reference Guide
- Wallet Card
- Next Steps Sheet
If the Eversense® E3 Smart Transmitter does not vibrate, try the following steps:
- Check that the smart transmitter is connected (paired) to your mobile device.
- Check that the Do Not Disturb is disabled by tapping Menu > Settings > Sound Settings.
- Check that your smart transmitter has enough battery power and charge if necessary.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
MKT-001692 Rev 1